MyFinsight
Home
Blog
About
Investments
$94,571K
(-2.05%↓ Y/Y)
Cash and cash
equivalents
$23,370K
(16.59%↑ Y/Y)
Prepaid expenses and
other current assets
$4,812K
(-19.10%↓ Y/Y)
Property and equipment,
gross
$4,477K
(0.43%↑ Y/Y)
Total current assets
$122,753K
(-0.06%↓ Y/Y)
Operating lease
right-of-use assets
$3,779K
(132.70%↑ Y/Y)
Restricted cash
$385K
(0.00%↑ Y/Y)
Property and equipment,
net
$71K
(-71.71%↓ Y/Y)
Less accumulated
depreciation
$4,406K
(4.73%↑ Y/Y)
Total assets
$126,988K
(1.52%↑ Y/Y)
Total liabilities and
stockholders equity
$126,988K
(1.52%↑ Y/Y)
Total stockholders
equity
$102,240K
(-7.88%↓ Y/Y)
Total liabilities
$24,748K
(75.59%↑ Y/Y)
Accumulated deficit
-$613,436K
(-19.92%↓ Y/Y)
Accumulated other
comprehensive loss
-$107K
(-174.36%↓ Y/Y)
Additional paid-in capital
$715,781K
(14.97%↑ Y/Y)
Total current
liabilities
$21,483K
(61.13%↑ Y/Y)
Operating lease
liabilities, noncurrent
$3,265K
(329.04%↑ Y/Y)
Common stock, 0.0001
par value...
$2K
(100.00%↑ Y/Y)
Accrued expenses
$15,230K
(99.08%↑ Y/Y)
Accounts payable
$5,254K
(31.75%↑ Y/Y)
Operating lease
liabilities
$999K
(-41.06%↓ Y/Y)
Back
Back
Balance Sheet
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
source: myfinsight.com